aspartic acid has been researched along with Cancer of Prostate in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (5.88) | 18.7374 |
| 1990's | 3 (17.65) | 18.2507 |
| 2000's | 4 (23.53) | 29.6817 |
| 2010's | 4 (23.53) | 24.3611 |
| 2020's | 5 (29.41) | 2.80 |
| Authors | Studies |
|---|---|
| Li, J; Lin, Y; Luo, Y; Qu, Z; Sun, Y; Yang, Z; Zhang, L; Zhang, X | 1 |
| Chen, H; Chen, J; Chen, X; Gu, Y; Huang, S; Wang, H; Wu, X; Xu, Y; Zhang, H; Zhang, Y | 1 |
| Andersen, MK; Balluff, B; Bathen, TF; Bertilsson, H; Buchholz, R; Claes, BSR; Ellis, SR; Giskeødegård, GF; Heeren, RMA; Høiem, TS; Karst, U; Krossa, S; Richardsen, E; Tessem, MB | 1 |
| Chen, J; Chen, Y; Li, L; Liu, T; Lv, W; Wang, K; Wang, X; Xu, S; Yang, W | 1 |
| Akinsiku, OE; Olotu, FA; Soliman, MES; Soremekun, OS | 1 |
| Knedlik, T; Konvalinka, J; Tykvart, J; Vorlova, B | 1 |
| He, S; Liu, J; Tao, M; Xu, K; Zhong, W | 1 |
| Friedman, AE; Friedman, MR; Kellersberger, KA; Lapek, JD; Tombline, G | 1 |
| Baek, HM; Choi, C; Ding, Y; Ganji, SK; Geethanath, S; Kodibagkar, VD; Lewis, MA; Maher, EA; Sims, RD | 1 |
| Costa, S; Ferreira, P; Lopes, C; Medeiros, RM; Morais, A; Oliveira, J; Pinto, D; Vasconcelos, A | 1 |
| FAGE, P | 1 |
| Denmeade, SR; Gady, AM; Gillies, SD; Lo, KM; Mhaka, A; Rosen, DM | 1 |
| Leach, F | 1 |
| Costello, LC; Franklin, RB; Yu, Z; Zou, J | 1 |
| Cleaveland, ES; Cooney, DA; Ford, H; Kelley, JA; Paull, K; Zaharevitz, DW | 1 |
| Endo, K; Nakano, K; Sakata, I; Suzuki, T; Tomiyoshi, K; Yamanaka, H | 1 |
| Costello, LC; Franklin, RB | 1 |
3 review(s) available for aspartic acid and Cancer of Prostate
| Article | Year |
|---|---|
Exploring the Role of Asp1116 in Selective Drug Targeting of CREBcAMP- Responsive Element-binding Protein Implicated in Prostate Cancer.
Topics: Aspartic Acid; Cyclic AMP Response Element-Binding Protein; Humans; Hydrogen Bonding; Indolizines; Male; Molecular Dynamics Simulation; Molecular Structure; Prostatic Neoplasms; Pyrazoles; Structure-Activity Relationship | 2020 |
GCPII and its close homolog GCPIII: from a neuropeptidase to a cancer marker and beyond.
Topics: Adenocarcinoma; Animals; Antibodies, Monoclonal; Antigens, Surface; Aspartic Acid; Biomarkers, Tumor; Brain; Carboxypeptidases; Disease Models, Animal; Glutamate Carboxypeptidase II; Glutamates; Humans; Hydrolysis; Inflammatory Bowel Diseases; Intestine, Small; Jejunum; Male; Mice; Mice, Mutant Strains; Mice, Transgenic; Neuropeptides; Peptide Hydrolases; Phenotype; Prostatic Neoplasms; Rats | 2019 |
Concepts of citrate production and secretion by prostate. 1. Metabolic relationships.
Topics: Aspartic Acid; Body Fluids; Citrates; Electrolytes; Humans; Kidney; Liver; Male; Oxidation-Reduction; Prostate; Prostatic Neoplasms; Zinc | 1991 |
14 other study(ies) available for aspartic acid and Cancer of Prostate
| Article | Year |
|---|---|
Effects of glutamate and aspartate on prostate cancer and breast cancer: a Mendelian randomization study.
Topics: Adult; Aspartic Acid; Breast Neoplasms; Glutamic Acid; Humans; Male; Mendelian Randomization Analysis; Prostatic Neoplasms | 2022 |
Study on the cellular internalization mechanisms and
Topics: Animals; Arginine; Aspartic Acid; Bone Neoplasms; Cell Line, Tumor; Cell Movement; Cell Survival; Cysteine; Genetic Vectors; Male; Membrane Proteins; Mice; Mice, Inbred BALB C; Nanoparticles; Particle Size; Peptide Fragments; Peptide T; Polyethylene Glycols; Prostatic Neoplasms; Tumor Burden | 2020 |
Simultaneous Detection of Zinc and Its Pathway Metabolites Using MALDI MS Imaging of Prostate Tissue.
Topics: Aspartic Acid; Citrates; Humans; Male; Prostate; Prostatic Neoplasms; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Time Factors; Zinc | 2020 |
Decreased glucose bioavailability and elevated aspartate metabolism in prostate cancer cells undergoing epithelial-mesenchymal transition.
Topics: Aspartic Acid; Biological Availability; Cell Line, Tumor; Cell Movement; Cell Proliferation; Epithelial-Mesenchymal Transition; Gene Expression Regulation, Neoplastic; Glucose; Humans; Male; Neoplasm Invasiveness; Prostate; Prostatic Neoplasms | 2020 |
In situ hydrogelation of forky peptides in prostate tissue for drug delivery.
Topics: Animals; Antineoplastic Agents; Aspartic Acid; Cations, Divalent; Cell Line, Tumor; Cell Survival; Cross-Linking Reagents; Doxorubicin; Drug Carriers; Humans; Hydrogels; Hydrogen-Ion Concentration; Male; Mice; NIH 3T3 Cells; Oligopeptides; Prostate; Prostatic Neoplasms; Zinc | 2019 |
Evidence of histidine and aspartic acid phosphorylation in human prostate cancer cells.
Topics: Aspartic Acid; Cell Line; Cell Line, Tumor; Histidine; Humans; Male; NM23 Nucleoside Diphosphate Kinases; Phosphorylation; Prostatic Neoplasms; Proteomics | 2015 |
Compressive sensing could accelerate 1H MR metabolic imaging in the clinic.
Topics: Algorithms; Analysis of Variance; Aspartic Acid; Brain Neoplasms; Choline; Citric Acid; Creatine; Data Compression; Female; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Spectroscopy; Male; Prostatic Neoplasms; Retrospective Studies | 2012 |
Outcome in prostate cancer: association with endothelial nitric oxide synthase Glu-Asp298 polymorphism at exon 7.
Topics: Aged; Aspartic Acid; Bone Neoplasms; Disease Progression; Exons; Genotype; Glutamic Acid; Humans; Logistic Models; Male; Middle Aged; Neoplasm Metastasis; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Polymorphism, Genetic; Prognosis; Prostatic Neoplasms; Treatment Outcome | 2002 |
[CLINICAL TRIALS OF A DRUG COMBINATION GROUPING THE ANTITOXIC FRACTIONS OF THE LIVER WITH ASPARTATES AND EXTRACTS OF THE LIVER WITH YEASTS].
Topics: Arteritis; Aspartic Acid; Drug Combinations; Geriatrics; Hernia, Diaphragmatic; Hernia, Hiatal; Humans; Liver Cirrhosis; Liver Extracts; Lung Neoplasms; Magnesium; Male; Polyradiculopathy; Potassium; Prostatic Neoplasms; Sinusitis; Tuberculosis; Tuberculosis, Pulmonary; Yeasts | 1964 |
Use of methotrexate-based peptide substrates to characterize the substrate specificity of prostate-specific membrane antigen (PSMA).
Topics: Animals; Antigens, Surface; Aspartic Acid; Blotting, Western; Extracellular Fluid; Glutamate Carboxypeptidase II; Glutamic Acid; Humans; Immunoglobulin gamma-Chains; Immunoglobulin kappa-Chains; Male; Methotrexate; Mice; Peptide Fragments; Prodrugs; Prostatic Neoplasms; Recombinant Fusion Proteins; Substrate Specificity; Tumor Cells, Cultured | 2004 |
Targeting prostate-specific membrane antigen in cancer therapy: can molecular medicine be brought to the surface?
Topics: Antigens, Surface; Aspartic Acid; Drug Delivery Systems; Glutamate Carboxypeptidase II; Glutamic Acid; Humans; Male; Methotrexate; Peptide Fragments; Prodrugs; Prostatic Neoplasms; Recombinant Fusion Proteins; Substrate Specificity | 2004 |
EAAC1 is expressed in rat and human prostate epithelial cells; functions as a high-affinity L-aspartate transporter; and is regulated by prolactin and testosterone.
Topics: Animals; Aspartic Acid; Biological Transport; Brain Chemistry; Cell Line, Tumor; Cells, Cultured; Citric Acid; Epithelial Cells; Excitatory Amino Acid Transporter 3; Gene Expression Regulation; Gene Expression Regulation, Neoplastic; Humans; Male; Neoplasm Proteins; Nerve Tissue Proteins; Prolactin; Prostate; Prostatic Neoplasms; Rats; Testosterone; Tetradecanoylphorbol Acetate | 2006 |
Identification of a novel inhibitor (NSC 665564) of dihydroorotate dehydrogenase with a potency equivalent to brequinar.
Topics: Antineoplastic Agents; Aspartic Acid; Biphenyl Compounds; Breast Neoplasms; Carbolines; Carcinoma, Non-Small-Cell Lung; Central Nervous System Neoplasms; Colonic Neoplasms; Dihydroorotate Dehydrogenase; Enzyme Inhibitors; Female; Humans; Kidney Neoplasms; Kinetics; Leukemia; Lung Neoplasms; Male; Melanoma; Mitochondria; Orotic Acid; Ovarian Neoplasms; Oxidoreductases; Oxidoreductases Acting on CH-CH Group Donors; Prostatic Neoplasms; Ribonucleotides; Sodium Bicarbonate; Software; Tumor Cells, Cultured | 1996 |
Contrast enhancement of PC-3 prostate cancer for magnetic resonance imaging: animal studies using tumor-localizing Mn-metalloporphyrin (THF-Mn-Asp).
Topics: Animals; Aspartic Acid; Contrast Media; Deuteroporphyrins; Gadolinium DTPA; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Mice; Mice, Nude; Organometallic Compounds; Pentetic Acid; Prostatic Neoplasms | 1996 |